The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Montelukast API Market Research Report 2025
Synopsis
The global Montelukast API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Montelukast API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Montelukast API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Montelukast API include Merck, Cipla, Morepen Laboratories, Sun Pharma, Teva Pharmaceutical Industries, Intas Pharmaceuticals, Apotex, Sanyo Chemical Industries and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Montelukast API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast API.
Report Scope
The Montelukast API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Montelukast API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Montelukast API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
Segment by Type
Tablet
Chewable Tablet
Oral Solution
Segment by Application
Asthma
Allergic Rhinitis
Urticaria
Bronchospasm
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Montelukast API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Montelukast API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Montelukast API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Montelukast API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Montelukast API include Merck, Cipla, Morepen Laboratories, Sun Pharma, Teva Pharmaceutical Industries, Intas Pharmaceuticals, Apotex, Sanyo Chemical Industries and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Montelukast API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast API.
Report Scope
The Montelukast API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Montelukast API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Montelukast API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
Segment by Type
Tablet
Chewable Tablet
Oral Solution
Segment by Application
Asthma
Allergic Rhinitis
Urticaria
Bronchospasm
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Montelukast API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Montelukast API Market Overview
1.1 Product Overview and Scope of Montelukast API
1.2 Montelukast API Segment by Type
1.2.1 Global Montelukast API Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Chewable Tablet
1.2.4 Oral Solution
1.3 Montelukast API Segment by Application
1.3.1 Global Montelukast API Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 Allergic Rhinitis
1.3.4 Urticaria
1.3.5 Bronchospasm
1.3.6 Others
1.4 Global Montelukast API Market Size Estimates and Forecasts
1.4.1 Global Montelukast API Revenue 2019-2030
1.4.2 Global Montelukast API Sales 2019-2030
1.4.3 Global Montelukast API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Montelukast API Market Competition by Manufacturers
2.1 Global Montelukast API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Montelukast API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Montelukast API Average Price by Manufacturers (2019-2024)
2.4 Global Montelukast API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Montelukast API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Montelukast API, Product Type & Application
2.7 Montelukast API Market Competitive Situation and Trends
2.7.1 Montelukast API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Montelukast API Players Market Share by Revenue
2.7.3 Global Montelukast API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Montelukast API Retrospective Market Scenario by Region
3.1 Global Montelukast API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Montelukast API Global Montelukast API Sales by Region: 2019-2030
3.2.1 Global Montelukast API Sales by Region: 2019-2024
3.2.2 Global Montelukast API Sales by Region: 2025-2030
3.3 Global Montelukast API Global Montelukast API Revenue by Region: 2019-2030
3.3.1 Global Montelukast API Revenue by Region: 2019-2024
3.3.2 Global Montelukast API Revenue by Region: 2025-2030
3.4 North America Montelukast API Market Facts & Figures by Country
3.4.1 North America Montelukast API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Montelukast API Sales by Country (2019-2030)
3.4.3 North America Montelukast API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Montelukast API Market Facts & Figures by Country
3.5.1 Europe Montelukast API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Montelukast API Sales by Country (2019-2030)
3.5.3 Europe Montelukast API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Montelukast API Market Facts & Figures by Country
3.6.1 Asia Pacific Montelukast API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Montelukast API Sales by Country (2019-2030)
3.6.3 Asia Pacific Montelukast API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Montelukast API Market Facts & Figures by Country
3.7.1 Latin America Montelukast API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Montelukast API Sales by Country (2019-2030)
3.7.3 Latin America Montelukast API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Montelukast API Market Facts & Figures by Country
3.8.1 Middle East and Africa Montelukast API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Montelukast API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Montelukast API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Montelukast API Sales by Type (2019-2030)
4.1.1 Global Montelukast API Sales by Type (2019-2024)
4.1.2 Global Montelukast API Sales by Type (2025-2030)
4.1.3 Global Montelukast API Sales Market Share by Type (2019-2030)
4.2 Global Montelukast API Revenue by Type (2019-2030)
4.2.1 Global Montelukast API Revenue by Type (2019-2024)
4.2.2 Global Montelukast API Revenue by Type (2025-2030)
4.2.3 Global Montelukast API Revenue Market Share by Type (2019-2030)
4.3 Global Montelukast API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Montelukast API Sales by Application (2019-2030)
5.1.1 Global Montelukast API Sales by Application (2019-2024)
5.1.2 Global Montelukast API Sales by Application (2025-2030)
5.1.3 Global Montelukast API Sales Market Share by Application (2019-2030)
5.2 Global Montelukast API Revenue by Application (2019-2030)
5.2.1 Global Montelukast API Revenue by Application (2019-2024)
5.2.2 Global Montelukast API Revenue by Application (2025-2030)
5.2.3 Global Montelukast API Revenue Market Share by Application (2019-2030)
5.3 Global Montelukast API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Montelukast API Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cipla Montelukast API Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 Morepen Laboratories
6.3.1 Morepen Laboratories Corporation Information
6.3.2 Morepen Laboratories Description and Business Overview
6.3.3 Morepen Laboratories Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Morepen Laboratories Montelukast API Product Portfolio
6.3.5 Morepen Laboratories Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma Montelukast API Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Industries Montelukast API Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Intas Pharmaceuticals
6.6.1 Intas Pharmaceuticals Corporation Information
6.6.2 Intas Pharmaceuticals Description and Business Overview
6.6.3 Intas Pharmaceuticals Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intas Pharmaceuticals Montelukast API Product Portfolio
6.6.5 Intas Pharmaceuticals Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Montelukast API Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sanyo Chemical Industries
6.8.1 Sanyo Chemical Industries Corporation Information
6.8.2 Sanyo Chemical Industries Description and Business Overview
6.8.3 Sanyo Chemical Industries Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanyo Chemical Industries Montelukast API Product Portfolio
6.8.5 Sanyo Chemical Industries Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Montelukast API Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Delmar Chemicals
6.10.1 Delmar Chemicals Corporation Information
6.10.2 Delmar Chemicals Description and Business Overview
6.10.3 Delmar Chemicals Montelukast API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Delmar Chemicals Montelukast API Product Portfolio
6.10.5 Delmar Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Montelukast API Industry Chain Analysis
7.2 Montelukast API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Montelukast API Production Mode & Process
7.4 Montelukast API Sales and Marketing
7.4.1 Montelukast API Sales Channels
7.4.2 Montelukast API Distributors
7.5 Montelukast API Customers
8 Montelukast API Market Dynamics
8.1 Montelukast API Industry Trends
8.2 Montelukast API Market Drivers
8.3 Montelukast API Market Challenges
8.4 Montelukast API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Montelukast API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Montelukast API Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Montelukast API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Montelukast API Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Montelukast API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Montelukast API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Montelukast API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Montelukast API Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Montelukast API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Montelukast API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Montelukast API, Product Type & Application
Table 12. Global Key Manufacturers of Montelukast API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Montelukast API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Montelukast API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Montelukast API Sales by Region (2019-2024) & (K Units)
Table 18. Global Montelukast API Sales Market Share by Region (2019-2024)
Table 19. Global Montelukast API Sales by Region (2025-2030) & (K Units)
Table 20. Global Montelukast API Sales Market Share by Region (2025-2030)
Table 21. Global Montelukast API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Montelukast API Revenue Market Share by Region (2019-2024)
Table 23. Global Montelukast API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Montelukast API Revenue Market Share by Region (2025-2030)
Table 25. North America Montelukast API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Montelukast API Sales by Country (2019-2024) & (K Units)
Table 27. North America Montelukast API Sales by Country (2025-2030) & (K Units)
Table 28. North America Montelukast API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Montelukast API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Montelukast API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Montelukast API Sales by Country (2019-2024) & (K Units)
Table 32. Europe Montelukast API Sales by Country (2025-2030) & (K Units)
Table 33. Europe Montelukast API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Montelukast API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Montelukast API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Montelukast API Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Montelukast API Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Montelukast API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Montelukast API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Montelukast API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Montelukast API Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Montelukast API Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Montelukast API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Montelukast API Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Montelukast API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Montelukast API Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Montelukast API Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Montelukast API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Montelukast API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Montelukast API Sales (K Units) by Type (2019-2024)
Table 51. Global Montelukast API Sales (K Units) by Type (2025-2030)
Table 52. Global Montelukast API Sales Market Share by Type (2019-2024)
Table 53. Global Montelukast API Sales Market Share by Type (2025-2030)
Table 54. Global Montelukast API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Montelukast API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Montelukast API Revenue Market Share by Type (2019-2024)
Table 57. Global Montelukast API Revenue Market Share by Type (2025-2030)
Table 58. Global Montelukast API Price (US$/Unit) by Type (2019-2024)
Table 59. Global Montelukast API Price (US$/Unit) by Type (2025-2030)
Table 60. Global Montelukast API Sales (K Units) by Application (2019-2024)
Table 61. Global Montelukast API Sales (K Units) by Application (2025-2030)
Table 62. Global Montelukast API Sales Market Share by Application (2019-2024)
Table 63. Global Montelukast API Sales Market Share by Application (2025-2030)
Table 64. Global Montelukast API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Montelukast API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Montelukast API Revenue Market Share by Application (2019-2024)
Table 67. Global Montelukast API Revenue Market Share by Application (2025-2030)
Table 68. Global Montelukast API Price (US$/Unit) by Application (2019-2024)
Table 69. Global Montelukast API Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Montelukast API Product
Table 74. Merck Recent Developments/Updates
Table 75. Cipla Corporation Information
Table 76. Cipla Description and Business Overview
Table 77. Cipla Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Cipla Montelukast API Product
Table 79. Cipla Recent Developments/Updates
Table 80. Morepen Laboratories Corporation Information
Table 81. Morepen Laboratories Description and Business Overview
Table 82. Morepen Laboratories Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Morepen Laboratories Montelukast API Product
Table 84. Morepen Laboratories Recent Developments/Updates
Table 85. Sun Pharma Corporation Information
Table 86. Sun Pharma Description and Business Overview
Table 87. Sun Pharma Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharma Montelukast API Product
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Corporation Information
Table 91. Teva Pharmaceutical Industries Description and Business Overview
Table 92. Teva Pharmaceutical Industries Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Industries Montelukast API Product
Table 94. Teva Pharmaceutical Industries Recent Developments/Updates
Table 95. Intas Pharmaceuticals Corporation Information
Table 96. Intas Pharmaceuticals Description and Business Overview
Table 97. Intas Pharmaceuticals Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Intas Pharmaceuticals Montelukast API Product
Table 99. Intas Pharmaceuticals Recent Developments/Updates
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Apotex Montelukast API Product
Table 104. Apotex Recent Developments/Updates
Table 105. Sanyo Chemical Industries Corporation Information
Table 106. Sanyo Chemical Industries Description and Business Overview
Table 107. Sanyo Chemical Industries Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sanyo Chemical Industries Montelukast API Product
Table 109. Sanyo Chemical Industries Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan Montelukast API Product
Table 114. Mylan Recent Developments/Updates
Table 115. Delmar Chemicals Corporation Information
Table 116. Delmar Chemicals Description and Business Overview
Table 117. Delmar Chemicals Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Delmar Chemicals Montelukast API Product
Table 119. Delmar Chemicals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Montelukast API Distributors List
Table 123. Montelukast API Customers List
Table 124. Montelukast API Market Trends
Table 125. Montelukast API Market Drivers
Table 126. Montelukast API Market Challenges
Table 127. Montelukast API Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Montelukast API
Figure 2. Global Montelukast API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Montelukast API Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Chewable Tablet Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Montelukast API Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Montelukast API Market Share by Application in 2023 & 2030
Figure 9. Asthma
Figure 10. Allergic Rhinitis
Figure 11. Urticaria
Figure 12. Bronchospasm
Figure 13. Others
Figure 14. Global Montelukast API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Montelukast API Market Size (2019-2030) & (US$ Million)
Figure 16. Global Montelukast API Sales (2019-2030) & (K Units)
Figure 17. Global Montelukast API Average Price (US$/Unit) & (2019-2030)
Figure 18. Montelukast API Report Years Considered
Figure 19. Montelukast API Sales Share by Manufacturers in 2023
Figure 20. Global Montelukast API Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Montelukast API Players: Market Share by Revenue in 2023
Figure 22. Montelukast API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Montelukast API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Montelukast API Sales Market Share by Country (2019-2030)
Figure 25. North America Montelukast API Revenue Market Share by Country (2019-2030)
Figure 26. United States Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Montelukast API Sales Market Share by Country (2019-2030)
Figure 29. Europe Montelukast API Revenue Market Share by Country (2019-2030)
Figure 30. Germany Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Montelukast API Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Montelukast API Revenue Market Share by Region (2019-2030)
Figure 37. China Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Montelukast API Sales Market Share by Country (2019-2030)
Figure 47. Latin America Montelukast API Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Montelukast API Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Montelukast API Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Montelukast API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Montelukast API by Type (2019-2030)
Figure 57. Global Revenue Market Share of Montelukast API by Type (2019-2030)
Figure 58. Global Montelukast API Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Montelukast API by Application (2019-2030)
Figure 60. Global Revenue Market Share of Montelukast API by Application (2019-2030)
Figure 61. Global Montelukast API Price (US$/Unit) by Application (2019-2030)
Figure 62. Montelukast API Value Chain
Figure 63. Montelukast API Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
